ACD Fellowship Program supports early-career researchers and investigators establishing labs in studying cerebral creatine deficiency syndromes, prioritizing research that advances progress toward the clinic.
Funder: Association for Creatine Deficiencies
Due Dates: October 1, 2026 (Applications open) | November 15, 2026 (Application deadline)
Funding Amounts: $15,000–$30,000 for one year, with the option to reapply for a second year
Summary: Supports cerebral creatine deficiency syndromes research, with preference for proposals advancing progress toward the clinic.
Key Information: Fellows must present at the 2027 CCDS Symposium and attend monthly fellowship update calls.
The Association for Creatine Deficiencies (ACD) Fellowship Program supports research in cerebral creatine deficiency syndromes (CCDS), including Creatine Transporter Deficiency, GAMT Deficiency, and AGAT Deficiency. It is intended for early-career researchers and principal investigators establishing their laboratories, including support for a staff resource in a new laboratory.
All research topics in this disease space will be considered, with preference given to proposals that facilitate progress toward the clinic. Examples include developing methods and assays for biomarkers, creating models and reagents, and screening drugs. The fellowship combines one year of research funding with opportunities to share findings and discuss progress through a symposium presentation and regular fellowship updates.